Industry News

Join the MWA and AVS Life Sciences Team at these upcoming industry events:


32nd Annual ISPE DVC Symposium and Exhibition, June 18, 2024 in Philadelphia, PA



ICH Q9(R1) Guideline reaches Step 4 of the ICH Process

The ICH Q9(R1) Guideline on Quality Risk Management reached Step 4 of the ICH Process. This Guideline is intended to provide guidance on the principles and examples of tools for quality risk management that can be applied to different aspects of pharmaceutical...

read more

MWA welcomes Michelle Hoover as Account Manager

MWA is pleased to announce that Michelle Hoover has joined our team as Account Manager. Michelle is an experienced client services leader in the pharmaceutical industry in areas of Contract Manufacturing, Supply Chain, and Development. She has over ten years of...

read more

New REMS Guidance Documents from FDA

FDA has released final guidance that provides updated recommendations for the format and content of a risk evaluation and mitigation strategy (REMS) document for a prescription drug product, including a biological drug product. A REMS document, which is part of a REMS...

read more